IDegLira improves time in range in a cohort of patients with type 2 diabetes: TiREX study
In T2D patients with poor metabolic control, either insulin naïve or treated with BOT or MDI, the introduction of IDegLira produces a significant increase in the time spent in good metabolic control and a marked reduction in glycemic fluctuations.
Authors
- Filomena Russo
- Federica Mazzoleni (ORCID: https://orcid.org/0009-0001-9895-8916)
- Roberta Serra (ORCID: https://orcid.org/0000-0002-3694-3620)
- Maria Elena Malighetti (ORCID: https://orcid.org/0000-0001-9021-8238)
- Antonio Bossi (ORCID: https://orcid.org/0000-0001-8900-1787)
- Emanuela Orsi
- Alessia Gaglio
- Laura Molteni (ORCID: https://orcid.org/0000-0001-6929-0243)
Institutions
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Casa di Cura San Michele (IT)
- Fatebenefratelli Hospital (IT)
- Humanitas Gavazzeni (IT)
- Ospedale di Monfalcone (IT)
- Ospedale San Giuseppe (IT)
- Azienda Ospedaliera Fatebenefratelli e Oftalmico (IT)
Publication Details
- Journal
- Acta Diabetologica
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1007/s00592-024-02361-7
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.72